La SATT Sayens annonce la signature d’un contrat de licence exclusive avec la biotech Oragen Therapeutics, ainsi qu’une prise de…
Making science
the future of innovation
Since 2013, Sayens has been bringing out promising scientific results, transforming them into innovation to benefit companies and start-ups, a source of growth and job creation.
Committed to working alongside researchers and companies to make science the future of innovation, Sayens promote the expertises of 6,500 researchers and 4,000 doctoral students from 140 public research laboratories in the Grand Est (Lorraine and South Champagne-Ardenne – Troyes) and Burgundy-Franche-Comté regions.
Why working
with Sayens?
Key figures as of December 31, 2024
931
Innovation disclosures since 2014
274
Intellectual Property assets
in portfolio
in portfolio
342
Projects in portfolio
42
M€ invested in 197 projects
44
start-up created
112
Active licenses
4.9
M€/year R&D turnover
8
Best state of the art R&D domains
